{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:14:51Z","timestamp":1768781691488,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CVRx Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0898-x","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T09:35:16Z","timestamp":1533807316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-2431","authenticated-orcid":false,"given":"Oleg","family":"Borisenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"M\u00fcller-Ehmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Rafflenbeul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"898_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803\u201369. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hfs105\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"898_CR2","unstructured":"National Institute for Cardiovascular Outcomes Research. The National Heart Failure Audit. April 2012\u2013March 2013. \n                    https:\/\/www.ucl.ac.uk\/nicor\/audits\/heartfailure\/documents\/annualreports\/hfannual12-13.pdf\n                    \n                  . Accessed 1 Sept 2016."},{"key":"898_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.hrtlng.2004.06.008","volume":"33","author":"WC Lee","year":"2004","unstructured":"Lee WC, Chavez YE, Baker T, Luce BR. Economic burden of heart failure: a summary of recent literature. Heart Lung. 2004;33:362\u201371.","journal-title":"Heart Lung"},{"key":"898_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/euhj.1998.1239","volume":"20","author":"A Mosterd","year":"1999","unstructured":"Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, et al. Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study Eur Heart J. 1999;20:447\u201355.","journal-title":"The Rotterdam Study Eur Heart J"},{"key":"898_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/euhj.1998.1280","volume":"20","author":"MR Cowie","year":"1999","unstructured":"Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20:421\u20138.","journal-title":"Eur Heart J"},{"key":"898_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejheart.2005.04.012","volume":"8","author":"CH van Jaarsveld","year":"2006","unstructured":"van Jaarsveld CH, Ranchor AV, Kempen GI, Coyne JC, van Veldhuisen DJ, Sanderman R. Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival. Eur J Heart Fail. 2006;8:23\u201330. \n                    https:\/\/doi.org\/10.1016\/j.ejheart.2005.04.012\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"898_CR7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3111\/13696998.2012.686464","volume":"15","author":"J St\u00e5lhammar","year":"2012","unstructured":"St\u00e5lhammar J, Stern L, Linder R, Sherman S, Parikh R, Ariely R, et al. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients. J Med Econ. 2012;15:938\u201346. \n                    https:\/\/doi.org\/10.3111\/13696998.2012.686464\n                    \n                  .","journal-title":"J Med Econ"},{"key":"898_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/hrt.2010.209171","volume":"97","author":"JG Cleland","year":"2011","unstructured":"Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ. The national heart failure audit for England and Wales 2008-2009. Heart. 2011;97:876\u201386. \n                    https:\/\/doi.org\/10.1136\/hrt.2010.209171\n                    \n                  .","journal-title":"Heart"},{"key":"898_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0272989X11401031","volume":"31","author":"PW Sullivan","year":"2011","unstructured":"Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Mak. 2011;31:800\u20134. \n                    https:\/\/doi.org\/10.1177\/0272989X11401031\n                    \n                  .","journal-title":"Med Decis Mak"},{"key":"898_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-8-13","volume":"8","author":"MT Dyer","year":"2010","unstructured":"Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. \n                    https:\/\/doi.org\/10.1186\/1477-7525-8-13\n                    \n                  .","journal-title":"Health Qual Life Outcomes"},{"key":"898_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1053\/euhj.1999.1985","volume":"21","author":"D Farwell","year":"2000","unstructured":"Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J. 2000;21:1246\u201350. \n                    https:\/\/doi.org\/10.1053\/euhj.1999.1985\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"898_CR12","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1001\/jama.297.22.2502","volume":"297","author":"FA McAlister","year":"2007","unstructured":"McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502\u201314. \n                    https:\/\/doi.org\/10.1001\/jama.297.22.2502\n                    \n                  .","journal-title":"JAMA"},{"key":"898_CR13","unstructured":"National Institute for Health and Care Excellence. Technology Appraisal Guidance Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314) \n                    https:\/\/www.nice.org.uk\/guidance\/ta314\n                    \n                  . Accessed 1 Sept 2016."},{"key":"898_CR14","unstructured":"Annual Report 2012. Eurotransplant International Foundation (2012). Eurotransplant International Foundation. \n                    https:\/\/www.eurotransplant.org\/cms\/mediaobject.php?file=AR2012.pdf\n                    \n                  . Accessed 1 Aug 2016."},{"key":"898_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/eurjhf\/hft127","volume":"15","author":"A Emin","year":"2013","unstructured":"Emin A, Rogers CA, Parameshwar J, Macgowan G, Taylor R, Yonan N, et al. Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail. 2013;15:1185\u201393. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hft127\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"898_CR16","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1016\/j.ejcts.2011.04.005","volume":"40","author":"JP Mazzucotelli","year":"2011","unstructured":"Mazzucotelli JP, Leprince P, Litzler PY, Vincentelli A, Le Guyader A, Kirsch M, et al. Results of mechanical circulatory support in France. Eur J Cardiothorac Surg. 2011;40:e112\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ejcts.2011.04.005\n                    \n                  .","journal-title":"Eur J Cardiothorac Surg"},{"key":"898_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, et al. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015;3:487\u201396. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2015.02.006\n                    \n                  .","journal-title":"JACC Heart Fail"},{"key":"898_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ejhf.299","volume":"17","author":"MR Zile","year":"2015","unstructured":"Zile MR, Abraham WT, Weaver FA, Butter C, Ducharme A, Halbach M, et al. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Eur J Heart Fail. 2015;17:1066\u201374. \n                    https:\/\/doi.org\/10.1002\/ejhf.299\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"898_CR19","doi-asserted-by":"publisher","unstructured":"Ford E, Adams J, Graves N. Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia. BMJ Open. 2012;2 \n                    https:\/\/doi.org\/10.1136\/bmjopen-2012-001094\n                    \n                  .","DOI":"10.1136\/bmjopen-2012-001094"},{"key":"898_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/eurheartj\/ehl382","volume":"28","author":"G Yao","year":"2007","unstructured":"Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007;28:42\u201351. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehl382\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"898_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","volume":"34","author":"SJ Pocock","year":"2013","unstructured":"Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, K\u00f8ber L, Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34:1404\u201313. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehs337\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"898_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10389-011-0452-0","volume":"20","author":"J Biermann","year":"2012","unstructured":"Biermann J, Neumann T, Angermann CE, D\u00fcngen HD, Erbel R, Herzog W, et al. Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German competence network heart failure vol 20. J Public Health. 2012;20:23\u201330.","journal-title":"J Public Health"},{"key":"898_CR23","unstructured":"Consumer Price Index. (2012) Federal Statistics Office. \n                    https:\/\/wwwdestatisde\/EN\/FactsFigures\/NationalEconomyEnvironment\/Prices\/ConsumerPriceIndices\/Tables_\/ConsumerPricesCategorieshtml?cms_gtp=151228_list%253D1%2526151226_slot%253D2&https=1\n                    \n                  . Accessed 1 Sept 2016."},{"key":"898_CR24","unstructured":"General Methods for the Assessment of the Relation of Benefits to Costs. Version 1.0 (2009). German national institute for quality and efficiency in health care. \n                    https:\/\/www.iqwig.de\/download\/General_Methods_for_the_Assessment_of_the_Relation_of_Benefits_to_Costs.pdf\n                    \n                  . Accessed 1 Sept 2016."},{"key":"898_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejheart.2005.01.012","volume":"7","author":"MJ Calvert","year":"2005","unstructured":"Calvert MJ, Freemantle N, Cleland JGF. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail. 2005;7:243\u201351. \n                    https:\/\/doi.org\/10.1016\/j.ejheart.2005.01.012\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"898_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683\u201390. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2011-301246\n                    \n                  .","journal-title":"Heart"},{"key":"898_CR27","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jclinepi.2004.01.020","volume":"57","author":"KG Moons","year":"2004","unstructured":"Moons KG, Donders AR, Steyerberg EW, Harrell FE. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol. 2004;57:1262\u201370. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2004.01.020\n                    \n                  .","journal-title":"J Clin Epidemiol"},{"key":"898_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/vhrm.2006.2.3.309","volume":"2","author":"DB Panagiotakos","year":"2006","unstructured":"Panagiotakos DB, Stavrinos V. Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models. Vasc Health Risk Manag. 2006;2:309\u201315.","journal-title":"Vasc Health Risk Manag"},{"key":"898_CR29","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768\u201377. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.849166\n                    \n                  .","journal-title":"Circulation"},{"key":"898_CR30","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.584102\n                    \n                  .","journal-title":"Circulation"},{"key":"898_CR31","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","volume":"95","author":"KD Aaronson","year":"1997","unstructured":"Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660\u20137.","journal-title":"Circulation"},{"key":"898_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.hrthm.2011.08.031","volume":"9","author":"DB Kramer","year":"2012","unstructured":"Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm. 2012;9:42\u20136. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2011.08.031\n                    \n                  .","journal-title":"Heart Rhythm"},{"key":"898_CR33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jacc.2012.07.028","volume":"60","author":"KC Bilchick","year":"2012","unstructured":"Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2012;60:1647\u201355. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.07.028\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"key":"898_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCHEARTFAILURE.112.000043","volume":"6","author":"AC Alba","year":"2013","unstructured":"Alba AC, Agoritsas T, Jankowski M, Courvoisier D, Walter SD, Guyatt GH, et al. Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail. 2013;6:881\u20139. \n                    https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000043\n                    \n                  .","journal-title":"Circ Heart Fail"},{"key":"898_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.amjmed.2003.07.016","volume":"116","author":"PA Cowper","year":"2004","unstructured":"Cowper PA, DeLong ER, Whellan DJ, Allen LaPointe NM, Califf RM. Economic effects of beta-blocker therapy in patients with heart failure. Am J Med. 2004;116:104\u201311.","journal-title":"Am J Med"},{"key":"898_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","volume":"6","author":"UC Hoppe","year":"2012","unstructured":"Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 2012;6:270\u20136. \n                    https:\/\/doi.org\/10.1016\/j.jash.2012.04.004\n                    \n                  .","journal-title":"J Am Soc Hypertens"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0898-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:08:56Z","timestamp":1565291336000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0898-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0898-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"18 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clinical data were obtained by the manufacturer (CVRx Inc., Minneapolis, MN, USA) with patient consent and after ethical approval. For the aims of present study, no further ethical approval was required, because the data were supplied by the manufacturer in an anonymous form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"OB is the employee of the medical consulting company Synergus AB, which received a grant from CVRx Inc. to develop a decision analytic model. JME has received speaker honoraria from CVRx Inc. JL provided paid consulting support to CVRx Inc. CH is the member of the Advisory Board to CVRx Inc. and has received speaker honoraria from CVRx Inc. ER does not have any conflict of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"163"}}